メリーランド州における潰瘍性大腸炎の臨床試験
メリーランド州内の拠点で、潰瘍性大腸炎に関する13件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳〜85歳 · 全性別 · 2026/10/01更新 · NCT07619547A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Capital Digestive Care, Chevy Chase
- Woodholme Gastroenterology, Glen Burnie
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 011, Glen Burnie
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395Immune Regulation in Ulcerative Colitis or Crohn s Disease
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
1 Day – 75 Years · 全性別 · 2026/09/28更新 · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Chevy Chase Clinical Research, Chevy Chase
- Woodholme Gastroenterology Associates, Glen Burnie
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Capital Digestive Care - Chevy Chase, Chevy Chase
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Capital Digestive Care - MGG Group - Chevy Chase Clinical Research, Chevy Chase
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Mercy Medical Center, Baltimore - Site Number: 8400117, Baltimore
- Mid-Atlantic GI Research, LLC - Site Number: 8400106, Greenbelt
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Mercy Medical Center, Baltimore
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase
- Woodholme Gastroenterology Associates PA, Glen Burnie
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Woodholme Gastroenterology Associates, Glen Burnie
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/05/22更新 · NCT06764615Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- Capital Digestive Care, Chevy Chase
被験者募集中観察研究
18歳以上 · 全性別 · 2025/05/08更新 · NCT06750731ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。